Botulinum Toxin-Induced Parotitis: A Postoperative Complication Following Masseter Muscle Injection
- PMID: 38438110
- DOI: 10.1016/j.joms.2024.02.007
Botulinum Toxin-Induced Parotitis: A Postoperative Complication Following Masseter Muscle Injection
Abstract
Botulinum toxin (BTX) injection is a common treatment for bruxism, but there is no literature on potential salivary gland complications. This paper presents a case of acute parotitis in a 60-year-old female following BTX injections to the masseter muscle. This case highlights the possible salivary gland complications after injection of BTX into the masticatory muscles. An electronic search of PubMed and Embase databases was conducted to create a literature review in order to delve into the etiology behind the presented case and suggest potential preventive measures to avoid salivary gland complications. Thirty-one articles are reviewed and discussed. Currently, there is no consensus on the causes of the mentioned complication. However, various factors have been proposed, encompassing anatomical, physiological, biological, and physical aspects. Several methods have been recommended for the safe injection of BTX, which, along with better medical training and knowledge, are warranted to achieve predictable results.
Copyright © 2024 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Comment in
-
RE: Botulinum Toxin-Induced Parotitis: A Postoperative Complication Following Masseter Muscle Injection.J Oral Maxillofac Surg. 2024 Sep;82(9):1030. doi: 10.1016/j.joms.2024.04.010. J Oral Maxillofac Surg. 2024. PMID: 39223003 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources